Monday’s cannabis equity session closed with the sector posting a modest net gain across the major multi-state operator names, capping a day defined by DEA rescheduling speculation, Q4 earnings-season positioning, and continued volatility in Canadian LP shares. Here is everything that moved the market today — and what traders are watching into Tuesday.
Monday Close: Key Levels and Sector Summary
The AdvisorShares Pure US Cannabis ETF (MSOS) finished the session near the upper end of its intraday range, reflecting institutional net-buying that accelerated into the close. Cannabis names that outperformed the broad market included several smaller MSO operators, while the large-cap Canadian LPs lagged after profit-taking pressure following last week’s short-covering rally.
Key tickers to watch from Monday’s close:
- CURLF (Curaleaf Holdings): Held above a key support level after a morning dip. The Florida-heavy retail footprint gives Curaleaf asymmetric upside in any adult-use ballot scenario before 2027. After-hours, no material news; price action expected to consolidate Tuesday.
- GTBIF (Green Thumb Industries): Finished near session highs after midday MSOS-driven buying. Q3 earnings remain the near-term catalyst — consensus expects GTI to again demonstrate profitability that sets it apart from peers.
- VRNOF (Verano Holdings): Quiet session on light volume. Verano’s Illinois and New Jersey revenue exposure makes it a proxy for high-tax-state operational efficiency. Watch for any Q3 pre-announcement guidance before October 15.
- TCNNF (Trulieve Cannabis): The Florida-dominant operator was among the relative outperformers Monday as any adult-use legalization catalyst in Florida would disproportionately benefit Trulieve’s unmatched in-state dispensary network.
After-Hours Developments to Watch
As of the 7 PM ET window, there are no major surprise earnings releases from cannabis names. However, macro-adjacent developments are worth monitoring:
- Federal Register Watch: Any DEA scheduling publication that lands after-hours would trigger significant overnight gap activity, particularly for GTBIF, CURLF, and VRNOF. The de facto probability of a Schedule III reclassification before year-end remains the dominant macro overhang for the entire sector.
- Canadian LP Guidance: OGI, CGC, and TLRY each face their own headwinds: OGI navigating German medical ramp-up, CGC executing on its U.S. re-entry strategy, and TLRY managing debt maturity timelines. None has reported after-hours Monday; check Tuesday pre-market for any guidance updates.
- Political Intelligence: Congressional calendar for the week of October 6 is light on cannabis-specific committee activity, reducing the likelihood of legislative headline risk Tuesday. This may allow the sector to trade technically rather than reactively.
Forward-Looking: Tuesday October 6 2026 Setup
Tuesday’s session sets up with a few key themes:
1. Q4 Earnings Season Entry — First Wave
The Q4 2026 cannabis earnings cycle begins in earnest mid-to-late October. Tuesday marks the start of analyst note season, when sell-side desks typically begin circulating Q3 preview memos. Any upgrades or downgrades on GTBIF, CURLF, or MSOS-adjacent names would create intraday momentum trades.
2. MSOS Rebalance Window
The AdvisorShares MSOS ETF operates on a monthly rebalance calendar. Traders should be aware that any mid-month reconstitution preview could shift relative weights between GTI, Curaleaf, Trulieve, and Verano — creating forced buying or selling activity independent of fundamentals.
3. Canadian Dollar and Cross-Border Flow
With CGC and TLRY USD-listed but CAD-revenue-dependent, Tuesday’s FX open will influence relative performance. A stronger CAD intraday would provide a modest tailwind to LP earnings translation — watch the 1.35 USD/CAD level as a near-term pivot.
Key Levels for Tuesday
Based on Monday’s price action and the broader sector setup, these are the technical signposts for October 6:
- MSOS: Resistance at Monday’s intraday high; a clean break higher would confirm institutional accumulation and could bring momentum buyers off the sidelines.
- CURLF: The support zone defined over the past week is critical — a close below it could trigger a retest of lower September levels.
- GTBIF: Pre-earnings drift higher is the base case scenario; any analyst note raising Q3 estimates would accelerate that move Tuesday.
Market Intelligence Summary
Monday, October 5, 2026 was a constructive session for cannabis equities — not a breakout day, but a day that confirmed underlying demand at key support levels. The DEA rescheduling overhang, Q4 earnings preview positioning, and sector-wide 280E tax relief optionality remain the three dominant themes heading into the back half of October.
Traders and investors looking for a deeper dive into individual tickers can explore the full Weedstock Cannabis Stock Tracker, which monitors real-time price action and fundamental metrics across the full cannabis equity universe.
Published by Sheeba M., Cannabis Market Intelligence Analyst, Weedstock.com. This article is for informational purposes only and does not constitute financial advice. Cannabis equities involve significant regulatory and market risk.